SLC12A5 and depressive disorder: Lastly, treatment with KCC2 activators, CLP290 and CLP257, restored the expression levels of KCC2 and the GABAAR α1 subunit, significantly alleviating depression-like behaviors induced by CSDS or ApoE-KD.